drugset / Trial / NCT02729441
Perindopril vs Ramipril for Persistence in MAU Reduction Study
RandomizedCrossoverOpen-labelTreatment
Summary
The investigators conducted a single center study controlled study involving 20 patients with Type 2 Diabetes and hypertension who were randomly assigned to receive ramipril 10mg or perindopril 8mg. The primary endpoint was difference in urine albumin-creatinine ratio at night time and during the day. Secondary endpoint was measurement of blood pressure.
Timeline
- Start
- 2010-04
- Primary completion
- 2012-08
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Perindopril | Small molecule | 8 mg | — |
| Comparator | Ramipril | Small molecule | 10 mg | — |